Cargando…

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma

SIMPLE SUMMARY: Soft tissue sarcomas are a group of malignant tumors developing from connective tissues in different parts of the human body. In the face of limited options for systemic therapy, immunotherapeutic approaches are currently being explored. In this context, cancer testis antigens (CTAs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albertsmeier, Markus, Altendorf-Hofmann, Annelore, Lindner, Lars H., Issels, Rolf D., Kampmann, Eric, Dürr, Hans-Roland, Schubert-Fritschle, Gabriele, Angele, Martin K., Kirchner, Thomas, Jungbluth, Achim A., Knösel, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761656/ https://www.ncbi.nlm.nih.gov/pubmed/33287125 http://dx.doi.org/10.3390/cancers12123612

Ejemplares similares

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
por: Albertsmeier, Markus, et al.
Publicado: (2022)

Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy
por: Berclaz, Luc M., et al.
Publicado: (2021)

TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
por: Berclaz, Luc M., et al.
Publicado: (2023)

Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma
por: Bücklein, Veit, et al.
Publicado: (2020)

Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor
por: Bösch, Florian, et al.
Publicado: (2020)

Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high grade urothelial carcinoma of the bladder
por: Hodgson, Anjelica, et al.
Publicado: (2019)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

A novel immune-related gene signature predicting survival in sarcoma patients
por: Ren, Haoyu, et al.
Publicado: (2021)

The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
por: Xu, Yichi, et al.
Publicado: (2020)

Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
por: Al-Khadairi, Ghaneya, et al.
Publicado: (2019)

Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms
por: Bösch, Florian, et al.
Publicado: (2022)

The Effect of Resection Margin on Local Recurrence and Survival in High Grade Soft Tissue Sarcoma of the Extremities: How Far Is Far Enough?
por: Bilgeri, Annika, et al.
Publicado: (2020)

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
por: Roszik, Jason, et al.
Publicado: (2017)

Amputation for Extremity Sarcoma: Indications and Outcomes
por: Kirilova, Maya, et al.
Publicado: (2021)

PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
por: Luk, Sietse J, et al.
Publicado: (2018)

Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients
por: Bücklein, Veit, et al.
Publicado: (2016)

Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients
por: Neuberger, Michael, et al.
Publicado: (2022)

The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas
por: Nettersheim, Daniel, et al.
Publicado: (2016)

Cancer‐testis antigens PRAME and NY‐ESO‐1 correlate with tumour grade and poor prognosis in myxoid liposarcoma
por: Iura, Kunio, et al.
Publicado: (2015)

Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery
por: Laurentius, Thea, et al.
Publicado: (2010)

HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)
por: Grillini, Marco, et al.
Publicado: (2022)

Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel Concepts
por: Schubert-Fritschle, Gabriele, et al.
Publicado: (2017)

The Expansion of the PRAME Gene Family in Eutheria
por: Chang, Ti-Cheng, et al.
Publicado: (2011)

Relative Sensitivity of Core-Needle Biopsy and Incisional Biopsy in the Diagnosis of Musculoskeletal Sarcomas
por: Klein, Alexander, et al.
Publicado: (2021)

Sarcomas of the extremities and the pelvis: comparing local recurrence after incisional and after core-needle biopsy
por: Klein, Alexander, et al.
Publicado: (2022)

Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells
por: Danilova, Anna, et al.
Publicado: (2020)

FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors
por: Briest, Franziska, et al.
Publicado: (2015)

PRAME expression and clinical outcome of breast cancer
por: Epping, M T, et al.
Publicado: (2008)

Lack of PRAME Expression in Cutaneous T-Cell Lymphomas
por: Bui, Chau M., et al.
Publicado: (2021)

PRAME expression is similar in scar and desmoplastic melanoma
por: Plotzke, Jaclyn M., et al.
Publicado: (2022)

PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023)

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors
por: Gérard, Catherine, et al.
Publicado: (2015)

Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
por: Bauschke, Astrid, et al.
Publicado: (2022)

Surgical treatment of liver metastases from non-colorectal non-neuroendocrine carcinomas
por: Bauschke, Astrid, et al.
Publicado: (2021)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
por: Al-Khadairi, Ghaneya, et al.
Publicado: (2019)

Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2(Prame) complex
por: Zhang, Wenjuan, et al.
Publicado: (2021)

Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis
por: Bauschke, Astrid, et al.
Publicado: (2020)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock
por: Muto, Yusuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_os8qcdqjdlitfha3ffikd442o5